2012
DOI: 10.4415/ann_12_02_10
|View full text |Cite
|
Sign up to set email alerts
|

Treating allergic rhinitis by sublingual immunotherapy: a review

Abstract: Abstract.Objective. Allergic rhinitis (AR) is a disease with high and increasing prevalence. The management of AR includes allergen avoidance, anti-allergic drugs, and allergen specific immunotherapy (AIT), but only the latter works on the causes of allergy and, due to its mechanisms of action, modifies the natural history of the disease. Sublingual immunotherapy (SLIT) was proposed in the 1990s as an option to traditional, subcutaneous immunotherapy. Material and methods. We reviewed all the available control… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
12
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(12 citation statements)
references
References 37 publications
0
12
0
Order By: Relevance
“…Most current therapeutic treatments for asthma target neutralization of inflammatory mediators and relieve local symptoms for only a short duration (5,6). Recently developed subcutaneous immunotherapy and sublingual immunotherapy to induce HDM-specific long-term tolerance have shown promising results in adults and children but such treatment required regular administration of high doses of HDM allergens for at least 3 years to show satisfactory clinical efficacy (7)(8)(9). Absence of a long-term solution to HDM-induced asthma in combination with the dangerous levels of HDM allergens present in households necessitates the requirement for a prophylactic vaccine that would switch the inflammatory immune response induced by HDM allergen to a protective immunity.…”
Section: Introductionmentioning
confidence: 99%
“…Most current therapeutic treatments for asthma target neutralization of inflammatory mediators and relieve local symptoms for only a short duration (5,6). Recently developed subcutaneous immunotherapy and sublingual immunotherapy to induce HDM-specific long-term tolerance have shown promising results in adults and children but such treatment required regular administration of high doses of HDM allergens for at least 3 years to show satisfactory clinical efficacy (7)(8)(9). Absence of a long-term solution to HDM-induced asthma in combination with the dangerous levels of HDM allergens present in households necessitates the requirement for a prophylactic vaccine that would switch the inflammatory immune response induced by HDM allergen to a protective immunity.…”
Section: Introductionmentioning
confidence: 99%
“…However, Shen's review had only 29 33 À0.67 [À12. 13,10.80] 0.91 Hsu 2010 (Social functioning) 29 33 3.33 [À5.80, 12.47] 0.47 Hsu 2010 (Role limitation due to emotional problems) 29 33 7.04 [À17. 15, 31.22] 0.57 Hsu 2010 (Mental health) 29 33 À4.13 [À15.…”
Section: Comparison With Other Reviewsmentioning
confidence: 99%
“…If medications appear to be inadequate, immunotherapy can be alternative choice . However, this therapy is inconvenient, with a few standardised allergens and risk of systemic anaphylactic reactions …”
mentioning
confidence: 99%
See 1 more Smart Citation
“…There are still some risks of adverse effects that range from mild local reactions like itching and swelling of the oral mucosa to severe systemic manifestation like anaphylaxis [9].…”
Section: Introductionmentioning
confidence: 99%